These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10555019)

  • 1. High-dose immunosuppressive therapy for rheumatoid arthritis: some answers, more questions.
    McSweeney PA; Furst DE; West SG
    Arthritis Rheum; 1999 Nov; 42(11):2269-74. PubMed ID: 10555019
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine and methotrexate for severe rheumatoid arthritis.
    Storb R; Thomas ED
    N Engl J Med; 1995 Dec; 333(23):1568; author reply 1568-9. PubMed ID: 7477182
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of relapse after autologous blood stem cell transplantation for severe rheumatoid arthritis.
    Pavletic SZ; Klassen LW; Pope R; O'Dell JR; Traynor AE; Haire CE; Graziano F; Oyama Y; Barr W; Burt RK
    J Rheumatol Suppl; 2001 Oct; 64():28-31. PubMed ID: 11642500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Basic therapeutic and immunosuppressive drugs in rheumatoid arthritis. No fear of "heavy weapons"].
    Krüger K
    MMW Fortschr Med; 2002 Aug; 144(33-34):25-30. PubMed ID: 12380140
    [No Abstract]   [Full Text] [Related]  

  • 5. Autologous stem cell transplantation in autoimmune diseases.
    Passweg J; Tyndall A
    Semin Hematol; 2007 Oct; 44(4):278-85. PubMed ID: 17961728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid arthritis.
    Emery P; Foster W; Suarez-Almazor M
    Clin Evid; 2002 Jun; (7):1101-21. PubMed ID: 12230730
    [No Abstract]   [Full Text] [Related]  

  • 7. Intensive immunosuppression with autologous hematopoietic stem cell reconstitution as therapy for rheumatoid arthritis.
    Klassen LW
    J Rheumatol Suppl; 2001 Oct; 64():3-4. PubMed ID: 11642501
    [No Abstract]   [Full Text] [Related]  

  • 8. High dose therapy and autologous hemopoietic stem cell transplantation in rheumatoid arthritis--the feasibility of phase III trials.
    Snowden J
    J Rheumatol Suppl; 2001 Oct; 64():55-9. PubMed ID: 11642507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities.
    van Oosterhout M; Verburg RJ; Levarht EW; Moolenburgh JD; Barge RM; Fibbe WE; van Laar JM
    Ann Rheum Dis; 2005 Dec; 64(12):1783-5. PubMed ID: 16284342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentostatin (Nipent) and high-dose cyclophosphamide for the treatment of refractory autoimmune disorders.
    Goodman M
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):67-71. PubMed ID: 10877056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose lymphoablative therapy (HDLT) with or without autologous stem-cell rescue for treatment of severe autoimmune diseases.
    Tecnologica MAP Suppl; 2001 Dec; ():29-9. PubMed ID: 11933938
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current therapeutic strategy for rheumatoid arthritis].
    Wollenhaupt J; Alten R; Burkhardt H; Edelmann E; Gromnica-Ihle E; Krause A; Krüger K; Manger B; Lorenz H; Müller-Ladner U; Nüsslein H; Pott HG; Tony H; Schneider M
    MMW Fortschr Med; 2006 Oct; 148(42):38-42; quiz 43. PubMed ID: 17621798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis.
    Bingham S; Veale D; Fearon U; Isaacs JD; Morgan G; Emery P; McGonagle D; Reece R; Clague R; Snowden JA
    Arthritis Rheum; 2002 Mar; 46(3):837-9. PubMed ID: 11920422
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy.
    Verburg RJ; Kruize AA; van den Hoogen FH; Fibbe WE; Petersen EJ; Preijers F; Sont JK; Barge RM; Bijlsma JW; van de Putte LB; Breedveld FC; van Laar JM
    Arthritis Rheum; 2001 Apr; 44(4):754-60. PubMed ID: 11315914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions.
    Bays AM; Gardner G
    Med Clin North Am; 2016 Jul; 100(4):719-31. PubMed ID: 27235612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive drug therapy].
    Elonen E
    Duodecim; 1986; 102(22):1684-9. PubMed ID: 3803258
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leflunomide (Arava) in the treatment of rheumatoid arthritis].
    Kaliterna DM
    Reumatizam; 2007; 54(2):67-8. PubMed ID: 18351143
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?
    McLean-Tooke A; Aldridge C; Waugh S; Spickett GP; Kay L
    Rheumatology (Oxford); 2009 Aug; 48(8):867-71. PubMed ID: 19447771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications with low dose methotrexate in rheumatoid arthritis.
    Kalke S; Balakrishnan C; Mittal G; Mangat G; Joshi VR
    J Assoc Physicians India; 1997 Nov; 45(11):903-4. PubMed ID: 11229210
    [No Abstract]   [Full Text] [Related]  

  • 20. Thalidomide in the treatment of refractory rheumatoid arthritis.
    Keesal N; Wasserman MJ; Bookman A; Lapp V; Weber DA; Keystone EC
    J Rheumatol; 1999 Nov; 26(11):2344-7. PubMed ID: 10555888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.